YBL-010

N/A

Report date: 2023/03/08 11:24:45

Base Information

Drug NameYBL-010

Drug Alias NameYBL-010

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsInterleukin-10 modulators

TargetsInterleukin-10

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesY-biologics Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesY-biologics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A